8-K: Safe & Green Secures $4.05M in Private Placement, Eyes Further Capital

Safe & Green Holdings Corp. has completed an initial private placement of Series C Convertible Preferred Stock, raising $4.05 million with potential for an additional $45.5 million.

Summary

• Safe & Green Holdings Corp. (SGBX) completed an initial private placement of 4,500 shares of Series C Convertible Preferred Stock for $4,050,000.
• The initial purchase price was paid in two tranches: $3,150,000 at the initial closing on November 28, 2025, and an additional $900,000 payable upon the effectiveness of the registration statement.
• The company may issue, and the institutional investor (JAK Industrial Ventures I LLC) may purchase, up to an additional 45,500 shares of Series C Preferred Stock, representing a maximum additional stated value of $45,500,000.
• Net proceeds to the company from the initial offering were approximately $2,799,500 after deducting placement agent fees (7.0% of gross proceeds) and other offering expenses ($25,000).
• The Series C Preferred Stock has a stated value of $1,000 per share and is convertible into Common Stock at an initial conversion price of $3.19 per share, subject to adjustment.
• Dividends on the Series C Preferred Stock accrue at 10% per annum and are payable in Common Stock, or can be capitalized, or paid in cash if certain equity conditions fail.
• The company is required to file a registration statement covering the resale of the Series C Preferred Stock and the underlying Common Stock.

Sentiment

Score: 5

Explanation: The filing details a necessary capital raise that provides immediate funding and potential for more, which is positive for liquidity. However, the terms of the preferred stock, including high dividends and significant investor protections, suggest a challenging financing environment and potential for substantial dilution for common shareholders, balancing the overall sentiment to neutral.

Positives

• Successfully secured $4.05 million in initial funding through a private placement.
• Potential to raise an additional $45.5 million through the sale of Additional Preferred Shares at the option of either the company or the investor.
• The capital raise is intended for general corporate purposes, providing financial flexibility.

Negatives

• Significant dilution potential from the conversion of Series C Preferred Stock into Common Stock, especially given the conversion amount is 110% of stated value plus dividends.
• High dividend rate of 10% per annum on the preferred stock, payable in shares or cash, which could further increase dilution or cash outflow.
• Substantial fees paid to the placement agent (7.0% of gross proceeds) and reimbursement for out-of-pocket expenses ($25,000), reducing net proceeds.
• The Series C Preferred Stock ranks senior to all other common stock with respect to dividends, distributions, and liquidation, potentially disadvantaging existing common shareholders.
• The company is subject to various covenants and restrictions, including limitations on incurring indebtedness, creating senior or pari passu stock, and certain asset transfers without Required Holders' consent.

Risks

• Dilution Risk: The conversion of Series C Preferred Stock into Common Stock, especially with the 110% conversion amount and dividend payments in shares, could significantly dilute existing common stockholders.
• Market Price Volatility: The conversion price and other terms are subject to adjustments based on market prices (VWAP, Closing Sale Price), which could lead to more shares being issued if the stock price declines.
• Liquidation Preference: In a liquidation event, Series C Preferred Stockholders are entitled to receive 125% of the Conversion Amount before any payments to common stockholders, or 100% after two years.
• Triggering Events: Various events, including trading suspensions, failure to timely convert shares, failure to maintain authorized shares, failure to pay dividends, or breaches of covenants, can trigger adverse consequences, including an increased dividend rate (Default Rate of 18%) or mandatory redemption.
• Exchange Cap Limitations: Issuance of Common Stock upon conversion is limited by Nasdaq listing rules (Exchange Cap) unless stockholder approval is obtained, potentially delaying conversions or requiring cash payments.
• Stockholder Approval Risk: Failure to obtain timely stockholder approval for the issuance of all Securities or for reverse stock splits could lead to ongoing obligations and potential penalties.
• Covenant Breaches: The company is subject to numerous covenants (e.g., on indebtedness, liens, restricted payments, asset transfers, business changes), and a breach could trigger a Triggering Event.
• Going Private Transaction Risk: In a "Going Private Transaction," the company may effect an optional redemption, potentially at a price that may not fully compensate holders for their investment opportunity.
• Regulatory Compliance: Failure to comply with SEC filing requirements (e.g., Form D, registration statements) or Principal Market listing rules could result in penalties or delisting.

Future Outlook

The company anticipates using the proceeds from the private placement for general corporate purposes and may raise additional capital through the sale of more Series C Preferred Stock. It is committed to obtaining stockholder approval for the issuance of all securities and potential reverse stock splits to maintain compliance with listing requirements and facilitate future capital raises.

Management Comments

• Michael McLaren, Chief Executive Officer of Safe & Green Holdings Corp., signed the Form 8-K and the Certificate of Designations.

Industry Context

This capital raise by Safe & Green Holdings Corp. reflects a common strategy for smaller public companies to secure funding, often through convertible preferred stock, to support operations and growth. The terms, including a high dividend rate and significant anti-dilution protections for the investor, suggest a challenging financing environment or a company in need of capital with limited alternatives. The requirement for stockholder approval for future share issuances and potential reverse stock splits indicates a focus on maintaining Nasdaq listing compliance, a critical factor for many small-cap companies.

Comparison to Industry Standards

• The 10% annual dividend rate on the Series C Preferred Stock is relatively high, often seen in riskier or distressed financing situations compared to typical preferred stock offerings from more established companies.
• The conversion amount being 110% of the stated value plus dividends provides a significant premium to the investor upon conversion, which is more favorable than standard 1:1 conversion ratios.
• The inclusion of extensive anti-dilution provisions and strong investor protections (e.g., Triggering Events, mandatory redemption clauses, participation rights in future placements) is typical for institutional private placements in companies with potentially volatile stock performance or higher perceived risk.
• The beneficial ownership limitation of 9.99% is a common "blocker" provision to prevent the investor from triggering beneficial ownership reporting requirements under Section 13(d) of the 1934 Act, or to avoid triggering certain corporate governance provisions.
• The requirement for stockholder approval for the issuance of all securities and potential reverse stock splits is a standard Nasdaq compliance measure, particularly for companies whose stock price may be nearing minimum bid requirements.

Corporate Governance

Stakeholder Impact

• Shareholders (Common Stock): Potential for significant dilution from the conversion of Series C Preferred Stock and payment of dividends in shares. Their equity interest will be junior to the Series C Preferred Stock in terms of dividends and liquidation. Required to vote on future share issuances and reverse stock splits.
• Investors (Series C Preferred Stock): Receive preferential treatment regarding dividends (10% per annum, potentially 18% on default) and liquidation. Benefit from strong anti-dilution protections and participation rights in future placements. Have significant control through "Required Holders" consent for various corporate actions.
• Company Operations: The capital infusion provides necessary funds for general corporate purposes, potentially supporting growth initiatives or shoring up liquidity. However, the restrictive covenants may limit strategic flexibility.
• Management: Must navigate complex financing terms, ensure compliance with numerous covenants, and secure stockholder approvals, adding to operational and governance responsibilities.

Next Steps

• File a registration statement covering the resale of the Series C Preferred Stock and underlying Common Stock.
• Obtain stockholder approval for the issuance of all Securities in compliance with Principal Market rules.
• Obtain stockholder approval for one or more reverse stock splits at an aggregate ratio less than or equal to 60 to 1 within twelve months of the Stockholder Approval Date.
• Hold a special meeting of stockholders by January 25, 2026, for the required approvals, with subsequent meetings every 60 days if approval is not obtained.
• Potentially conduct additional closings for the sale of up to 45,500 more Series C Preferred Shares.
• Maintain compliance with all covenants outlined in the Certificate of Designations and Securities Purchase Agreement.

Key Dates

Recommendation

The capital raise provides essential funding for Safe & Green Holdings Corp., addressing immediate liquidity needs and offering potential for further capital. This is a positive for the company's short-term stability. However, the terms of the Series C Preferred Stock are highly dilutive for existing common shareholders due to the conversion premium, high dividend rate (payable in shares), and extensive investor protections. The company also faces significant covenants and the need for stockholder approval for future equity actions, which could constrain future flexibility. Given the immediate capital infusion but also the substantial long-term dilution and restrictive terms, a 'hold' recommendation is appropriate. Investors should monitor the company's use of proceeds, progress on stockholder approvals, and the impact of future conversions on common stock value before considering further investment.

Keywords

Private Placement, Series C Preferred Stock, Convertible Securities, Capital Raise, SEC Filing, Form 8-K, Dilution, Corporate Governance, Registration Rights, SGBX, Financial Health, Investment, Preferred Stock, Equity Financing